University of Pittsburgh Medical Center, Division of Newborn Medicine. 4401 Penn Ave, Pittsburgh, PA, USA 15224.
University of Pittsburgh Medical Center, Division of Pediatric General and Thoracic Surgery. 4401 Penn Ave, Pittsburgh, PA, USA 15224.
J Pediatr Surg. 2023 Mar;58(3):389-396. doi: 10.1016/j.jpedsurg.2022.07.022. Epub 2022 Aug 1.
Infants with congenital diaphragmatic hernia (CDH) are at high risk of death, even despite extracorporeal membrane oxygenation (ECMO) support. In January 2012 we implemented a standardized clinical practice guideline (CPG) to manage infants with CDH. We hypothesized that infants with CDH managed with CPG had better clinical outcomes, less ECMO utilization, and increased survival to discharge.
We conducted a retrospective pre-post study of infants with CDH admitted between January 2007 and July 2021 (n = 133). Patients were divided into Cohort 1, pre-CPG (January 2007 to December 2011, n = 54), and Cohort 2, post-CPG (January 2012 to July 2021, n = 79).
More patients in Cohort 1 were small for gestational age than in Cohort 2. No other patient demographics were different between cohorts. Cohort 2 had significantly lower ECMO utilization as compared to Cohort 1 (18% vs 50%, p<0.001). Cohort 2 had significantly higher survival to discharge compared to Cohort 1 (85% vs 57%, p<0.001). Survival for ECMO-treated patients in Cohort 2 was significantly higher than in Cohort 1 (71% vs 26%, p = 0.005). In Cohort 1, 70% of the non-survivors were repaired, of which 81% were repaired on ECMO. In Cohort 2, 8% of the non-survivors were repaired, none on ECMO. Only 3% in Cohort 2 were discharged with pulmonary hypertension medication.
A standardized CPG to manage patients with CDH decreased ECMO utilization and improved clinical outcomes including survival to discharge. Refinement of management strategies, implementation of new interventions, and meticulous care can improve outcomes in patients with CDH.
患有先天性膈疝(CDH)的婴儿即使有体外膜肺氧合(ECMO)支持,其死亡率仍很高。2012 年 1 月,我们实施了一项标准化的临床实践指南(CPG)来管理患有 CDH 的婴儿。我们假设,按照 CPG 管理的 CDH 婴儿具有更好的临床结局,更少的 ECMO 利用,并增加存活至出院的机会。
我们对 2007 年 1 月至 2021 年 7 月期间收治的 CDH 婴儿进行了回顾性前后研究(n=133)。患者分为 Cohort 1,CPG 前(2007 年 1 月至 2011 年 12 月,n=54)和 Cohort 2,CPG 后(2012 年 1 月至 2021 年 7 月,n=79)。
与 Cohort 2 相比,Cohort 1 中更多的患者为小于胎龄儿。两组间无其他患者人口统计学差异。与 Cohort 1 相比,Cohort 2 的 ECMO 利用率显著降低(18%比 50%,p<0.001)。与 Cohort 1 相比,Cohort 2 的出院存活率显著升高(85%比 57%,p<0.001)。在 Cohort 2 中,接受 ECMO 治疗的患者存活率明显高于 Cohort 1(71%比 26%,p=0.005)。在 Cohort 1 中,70%的死亡患者接受了修复手术,其中 81%在 ECMO 上进行了修复。在 Cohort 2 中,8%的死亡患者接受了修复手术,均未在 ECMO 上进行。在 Cohort 2 中,只有 3%的患者出院时需要服用肺动脉高压药物。
管理 CDH 患者的标准化 CPG 降低了 ECMO 的利用,并改善了包括出院存活率在内的临床结局。细化管理策略、实施新的干预措施和精心护理可以提高 CDH 患者的结局。